Status:
COMPLETED
Bergen Oral Respiratory Intervention Study
Lead Sponsor:
Anders Røsland
Collaborating Sponsors:
European Research Council
Uppsala University
Conditions:
Periodontitis
Airway Obstruction
Eligibility:
All Genders
25-45 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate if treatment of periodontitis (gum disease) in a relatively young and healthy population can improve lung function. It is hypothesized that removing the den...
Detailed Description
After being informed about the study and potential risks, all participants giving written informed consent will undergo a clinical screening to determine eligibility for study entry. The study partic...
Eligibility Criteria
Inclusion
- clinical diagnosis of periodontitis (stadium I or II)
- measures of periodontal infection (PI) \> 50%
- inflammation (bleeding index/bleeding on probing) \> 50%
- never-smoker
Exclusion
- asthma
- symptoms of pollen allergy
- chronic lung diseases
- daily medication use which may interfere with the evaluation of the subject
- pregnancy
- use of systemic antibiotics last six months
- subgingival scaling last six months
- regularly use of oral antiseptic mouth rinse
- use of snus (moist/smokeless tobacco)
- current medical condition which may interfere with the evaluation of the subject
Key Trial Info
Start Date :
April 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 27 2024
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04781153
Start Date
April 27 2021
End Date
June 27 2024
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Dentistry, University of Bergen
Bergen, BERGEN, Norway, 5009